Gritstone bio, Inc.

Industry

  • Biotechnology
    • Drug Discovery Technologies
      • Bioinformatics
      • Genomics-Proteomics
  • Pharmaceuticals
    • Vaccines
    • Specialty Pharmaceuticals
  • Digital Health
    • Artificial Intelligence

Other Names/Subsidiaries

  • Gritstone Oncology
See more in Biomedtracker

Latest on Gritstone bio, Inc.

Scrip

Finance Watch: 2024 Has Now Beaten 2023’s Total Of 21 IPOs

 
• By Mandy Jackson

The number of biopharmaceutical companies that have gone public in the US in 2024 has now beat the 2023 total of 21 with the 10 October initial public offerings by Upstream Bio Inc. and CAMP4 Thera

Scrip

Finance Watch: Biopharma IPO Queue Grows As Market Conditions Improve

 
• By Mandy Jackson

The market for initial public offerings in the US heated up in September with five biopharmaceutical companies launching IPOs, the second busiest month for first-time offerings in 2024 after there wer

Scrip

Granite Weighs Gritstone Down

 
• By Elizabeth Cairns

After the markets closed on 30 September Gritstone bio, Inc. quietly admitted that the Phase II colorectal cancer trial of its neoantigen therapy Granite had disappointed. The news, coming on top of

Scrip

Finance Watch: Kronos Reveals Second Round Of Job Cuts In Five Months

 
• By Mandy Jackson

Kronos Bio, Inc. implemented a restructuring plan in November that resulted in a 19% workforce reduction but extended its cash runway into 2026 and the company unveiled further cost cuts on 7 March t